We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
+15.35%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$2.04B
AUM Growth
+$121M
Cap. Flow
-$60.1M
Cap. Flow %
-2.95%
Top 10 Hldgs %
32.32%
Holding
334
New
52
Increased
46
Reduced
60
Closed
62

Top Buys

Rank Stock Value
1
XLI icon
State Street Industrial Select Sector SPDR ETF
XLI
+$45M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$23.9M
3
NKE icon
Nike
NKE
+$22.3M
4
SYK icon
Stryker
SYK
+$20.4M
5
NVDA icon
NVIDIA
NVDA
+$19.3M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$37.2M
2
SCHW
Charles Schwab
SCHW
+$21.8M
3
IWN icon
iShares Russell 2000 Value ETF
IWN
+$20.7M
4
LULU icon
lululemon athletica
LULU
+$19M
5
CME icon
CME Group
CME
+$18.8M

Sector Composition

Rank Sector Weight
1 Technology 25.65%
2 Consumer Discretionary 16.65%
3 Healthcare 13.39%
4 Miscellaneous 10.22%
5 Financials 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HALO icon
301
Halozyme
HALO
$12.1B
– –
-205,680
Closed -$11.7M
HBAN icon
302
Huntington Bancshares
HBAN
$33.8B
– –
-435,700
Closed -$6.14M
HP icon
303
Helmerich & Payne
HP
$4.34B
– –
-38,940
Closed -$1.93M
HRMY icon
304
Harmony Biosciences
HRMY
$2.46B
– –
-80,140
Closed -$4.42M
IWN icon
305
iShares Russell 2000 Value ETF
IWN
$14.2B
– –
-149,530
Closed -$20.7M
KEY icon
306
KeyCorp
KEY
$23.2B
– –
-501,240
Closed -$8.73M
LNTH icon
307
Lantheus
LNTH
$6.58B
– –
-84,850
Closed -$4.32M
MXL icon
308
MaxLinear
MXL
$6.09B
– –
-90,922
Closed -$3.09M
NBIX icon
309
Neurocrine Biosciences
NBIX
$15.2B
– –
-53,600
Closed -$6.4M
NVEE
310
DELISTED
NV5 Global
NVEE
– –
-197,896
Closed -$6.55M
PCTY icon
311
Paylocity
PCTY
$7.81B
– –
-1,570
Closed -$305K
PFGC icon
312
Performance Food Group
PFGC
$14B
– –
-115,860
Closed -$6.77M
PNC icon
313
PNC Financial Services
PNC
$96.1B
– –
-12,985
Closed -$2.05M
PNFP icon
314
Pinnacle Financial Partners Inc
PNFP
$15B
– –
-31,380
Closed -$2.3M
PRCT icon
315
Procept Biorobotics
PRCT
$1.11B
– –
-67,960
Closed -$2.82M
PRVA icon
316
Privia Health
PRVA
$2.6B
– –
-146,645
Closed -$3.33M
PTEN icon
317
Patterson-UTI
PTEN
$4.85B
– –
-164,820
Closed -$2.78M
RRC icon
318
Range Resources
RRC
$9.79B
– –
-30,460
Closed -$762K
SMCI icon
319
Super Micro Computer
SMCI
$23.4B
– –
-283,050
Closed -$2.32M
SRPT icon
320
Sarepta Therapeutics
SRPT
$2.19B
– –
-41,440
Closed -$5.37M
STE icon
321
Steris
STE
$20.5B
– –
-2,560
Closed -$473K
STKL
322
DELISTED
SunOpta
STKL
– –
-270,480
Closed -$2.28M
TYL icon
323
Tyler Technologies
TYL
$14.5B
– –
-1,770
Closed -$571K
UTHR icon
324
United Therapeutics
UTHR
$21.5B
– –
-1,850
Closed -$514K
WFC icon
325
Wells Fargo
WFC
$271B
– –
-134,700
Closed -$5.56M
10 11 12
13
14

Similar funds

MSC
MUFG Securities (Canada) New York $3.71B AUM 38.19% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
HCM
Himalaya Capital Management Seattle, Washington $3.7B AUM 39.18% 1-Year Est. Return
OH
Osiris Holdings Monaco $3.72B AUM
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.7B AUM 32.64% 1-Year Est. Return
MCM
MKP Capital Management New York $3.7B AUM 23.18% 1-Year Est. Return

Castleark Management's Q1 2023 Portfolio in Review

As of Q1 2023, Castleark Management held 334 positions worth $2.04B, up 6.3% from $1.91B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Castleark Management's Q1 2023 filing shows 52 new, 46 increased, 60 reduced and 62 closed positions. Its largest new stake was State Street Industrial Select Sector SPDR ETF: 447,010 shares worth $45.2M. The largest sale was State Street SPDR S&P Biotech ETF, an estimated $37.2M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Castleark Management's largest Q1 2023 buy was State Street Industrial Select Sector SPDR ETF: 447,010 shares worth $45.2M.
  • Castleark Management added most to iShares MSCI EAFE ETF in Q1 2023, an estimated $23.9M increase.
  • Castleark Management's biggest Q1 2023 reduction was Charles Schwab, cutting an estimated $21.8M.
  • Castleark Management fully exited State Street SPDR S&P Biotech ETF in Q1 2023, selling an estimated $37.2M.
  • Castleark Management's ten largest holdings make up 32% of its $2.04B portfolio in Q1 2023.
  • Castleark Management opened 52 new positions and closed 62 in Q1 2023.
  • Castleark Management's portfolio value rose 6.3% quarter-over-quarter to $2.04B.

Based on Castleark Management's 13F filing for Q1 2023, filed 16 May 2023.